--- title: "The Summer Awakening: A Deep-Tech IPO Frenzy and the AI Rebuild of Legacy Giants" type: "News" locale: "en" url: "https://longbridge.com/en/news/292398002.md" description: "Capital is aggressively repricing niche industry leaders. As hardware players like Nexchip go public with massive oversubscriptions, established powerhouses including SenseTime are quietly overhauling foundational AI infrastructure." datetime: "2026-07-12T09:13:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292398002.md) - [en](https://longbridge.com/en/news/292398002.md) - [zh-HK](https://longbridge.com/zh-HK/news/292398002.md) --- # The Summer Awakening: A Deep-Tech IPO Frenzy and the AI Rebuild of Legacy Giants I'm told that the Hong Kong capital market has been unusually loud over the past week. If you only look at the macro narratives, you might think everything is proceeding at a sluggish, business-as-usual pace. But the truth, as usual, is more complicated. Rewind to the second week of July 2026, and you'll notice a distinct signal hidden in the density of new stock issuances and the quiet maneuvering of legacy giants: capital is aggressively repricing next-generation tech infrastructure and niche industry champions. This matters because it shatters the prevailing stereotype that the Hong Kong market is suffering from a structural lack of liquidity. The story begins with a flurry of IPOs in early July. Between July 8 and July 10, 2026, several heavyweight hard-tech companies went public in rapid succession. The most striking of these was **Nexchip (2249.HK)**. As a 12-inch pure wafer foundry focusing on 150nm to 40nm process technologies, its Hong Kong public offering was oversubscribed by a staggering 344 times, raising net proceeds of approximately HKD 6.78B. The stock saw immense enthusiasm from capital right out of the gate. And this wasn't an isolated incident. In the exact same week, **BASiC Semiconductor (9971.HK)**, a leading IDM for silicon carbide power devices, successfully listed with retail tranches oversubscribed by nearly 4,800 times. Investors are voting with their wallets: in the grand narrative of semiconductor self-sufficiency, companies with core wafer manufacturing capabilities remain incredibly scarce and valuable. And yet, if you think this is purely a semiconductor party, you'd be mistaken. On July 9, **CCTC (6951.HK)**, a deep-tech player in electronic ceramic materials, made its debut, completing a dual "A+H" listing. Looking at their recent financials, Q1 2026 revenue hit RMB 2.68B, up 46% year-over-year. Even a highly specialized consumer brand like **Qiyunshan Food (2797.HK)** went public the same day, securing over 1,688 times oversubscription and experiencing a massive surge on its first day of trading. These new faces paint a clear picture: the market is no longer chasing abstract concepts, but is willing to pay a premium for "hidden champions" with real revenue backing. But the exuberance of the newcomers shouldn't obscure the anxiety and ambition of the established giants. In an era redefined by AI and compute, legacy telecommunications and technology powerhouses are undergoing a profound foundational rebuild. **SenseTime (0020.HK)** is a prime example. I'm told the company is set to officially release its next-generation flagship multimodal foundation model, U1 Pro, next week. From the SenseCore infrastructure to the native multimodal architecture NEO, SenseTime is trying to prove that it can secure a foundational position in the generative AI era just as it did in the AI 1.0 facial recognition days. However, supporting a massive AI compute network requires upgrading the underlying physical infrastructure. This is exactly what **China Mobile (0941.HK)** is doing. The telecom giant recently launched its largest ordinary fiber optic cable procurement of the year—nearly 70 million core kilometers—while simultaneously establishing industry standards for 5G embodied intelligent robot networking modules with industry partners. These seemingly mundane infrastructure investments are the actual arteries that will keep future embodied AI alive. Beyond all this, there are giants like **Wuxi Biologics (2269.HK)** navigating complex geopolitical and industry cycles. On July 9, 2026, the company announced that its MFG8 drug substance facility in Shijiazhuang passed the pre-license inspection (PLI) by the US FDA. While a major competitor faced internal strikes, Wuxi Biologics has been aggressively repurchasing shares, spending over HKD 1.17B this year, and its recent stock performance has shown signs of recovery. New guards enter, old cycles turn. A fresh generation of hard-tech companies is marching into the Hong Kong exchange backed by massive oversubscriptions, while older giants search for new moats amidst fiber optics, large language models, and FDA inspections. Capital is always hunting for the next compelling story. As for how many of these stories will eventually translate into free cash flow? Good luck with that. _This article does not constitute investment advice._ ### Related Stocks - [06951.HK](https://longbridge.com/en/quote/06951.HK.md) - [02249.HK](https://longbridge.com/en/quote/02249.HK.md) - [02269.HK](https://longbridge.com/en/quote/02269.HK.md) - [02797.HK](https://longbridge.com/en/quote/02797.HK.md) - [09971.HK](https://longbridge.com/en/quote/09971.HK.md) ## Related News & Research - [WuXi Biologics’ MFG8 drug substance plant passes FDA pre-license inspection](https://longbridge.com/en/news/292135693.md) - [WuXi Biologics files HKEX next-day disclosure showing 206,000 new shares issued via option exercises](https://longbridge.com/en/news/291944400.md) - [WuXi Biologics retains MSCI ESG AAA rating for fourth straight year under Model 5.0](https://longbridge.com/en/news/291992581.md) - [CANbridge Pharmaceuticals delays EGM circular dispatch to on or before July 20, 2026](https://longbridge.com/en/news/292169145.md) - [BASiC Semiconductor to Lift Select Product Prices Amid Surging AI and EV Demand](https://longbridge.com/en/news/292411185.md)